| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology, Pathobiology, and Genetics |
1 National Institute of Public Health and the Environment, Laboratory of Toxicology, Pathology, and Genetics, Bilthoven; 2 Josephine Nefkens Institute, Erasmus MC, Rotterdam, the Netherlands; and 3 Center for Cancer Research, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts
Requests for reprints: Annemieke de Vries, National Institute of Public Health and the Environment, Laboratory of Toxicology, Pathology, and Genetics, 3720 BA Bilthoven, the Netherlands. Phone: 31-30-274-3483; Fax: 31-30-274-4446; E-mail: Annemieke.de.Vries{at}rivm.nl.
Cellular activity of the tumor suppressor protein p53 is primarily regulated by posttranslational modifications. Phosphorylation of the COOH terminus, including Ser389, is thought to result in a conformational change of the p53 protein, enhancing DNA binding and transcriptional activity. In vitro studies presented here show that, in addition to UV radiation, Ser389 is phosphorylated upon exposure to 2-acetylaminofluorene (2-AAF). Both agents induce bulky DNA adducts repaired by nucleotide excision repair (NER). In contrast, ionizing radiation, known to induce DNA damage not repaired by NER, does not result in Ser389 phosphorylation. Previously, we have shown that p53.S389A mutant mice, lacking the Ser389 phosphorylation site, are sensitive to developing UV-induced skin tumors. Here, we show that p53.S389A mice are also prone to developing 2-AAFinduced urinary bladder tumors, whereas no increased tumor response was found upon ionizing irradiation. These results provide evidence for our hypothesis that phosphorylation of Ser389 is important for activation of p53 to exert its function as a tumor suppressor not exclusively upon the presence of UV-induced DNA damage, but also upon exposure to other bulky adduct-inducing agents. Analysis of 2-AAF and UV-induced tumors from p53.S389A mice revealed the presence of additional p53 mutations, indicating that lack of Ser389 phosphorylation by itself is not sufficient to abrogate p53 function in tumor suppression. In addition, analyses of skin tumors of p53.S389A mice revealed an interesting hotspot mutation previously found exclusively in NER-deficient mice and patients.
This article has been cited by other articles:
![]() |
W. Bruins, O. Bruning, M. J. Jonker, E. Zwart, T. V. van der Hoeven, J. L. A. Pennings, H. Rauwerda, A. de Vries, and T. M. Breit The Absence of Ser389 Phosphorylation in p53 Affects the Basal Gene Expression Level of Many p53-Dependent Genes and Alters the Biphasic Response to UV Exposure in Mouse Embryonic Fibroblasts Mol. Cell. Biol., March 15, 2008; 28(6): 1974 - 1987. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Oster, B. Bundgaard, T. R. Hupp, and P. Hollsberg Human herpesvirus 6B induces phosphorylation of p53 in its regulatory domain by a CK2- and p38-independent pathway J. Gen. Virol., January 1, 2008; 89(1): 87 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Bruins, M. J. Jonker, O. Bruning, J. L.A. Pennings, M. M. Schaap, E. M. Hoogervorst, H. van Steeg, T. M. Breit, and A. de Vries Delayed expression of apoptotic and cell-cycle control genes in carcinogen-exposed bladders of mice lacking p53.S389 phosphorylation Carcinogenesis, August 1, 2007; 28(8): 1814 - 1823. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W.P. Wijnhoven, E. N. Speksnijder, X. Liu, E. Zwart, C. Th. M. vanOostrom, R. B. Beems, E. M. Hoogervorst, M. M. Schaap, L. D. Attardi, T. Jacks, et al. Dominant-Negative but not Gain-of-Function Effects of a p53.R270H Mutation in Mouse Epithelium Tissue after DNA Damage Cancer Res., May 15, 2007; 67(10): 4648 - 4656. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Moiseeva, F. A. Mallette, U. K. Mukhopadhyay, A. Moores, and G. Ferbeyre DNA Damage Signaling and p53-dependent Senescence after Prolonged beta-Interferon Stimulation Mol. Biol. Cell, April 1, 2006; 17(4): 1583 - 1592. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |